
NYSEHealthcareMedical - Instruments & Supplies
最新データ
$366
+$2.73 · +0.75%
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
前日終値
$366
+$2.73 · +0.75%
日中の時刻はETです。市場データは遅延する場合があります。
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
日中レンジ
現在 $366
52週レンジ
現在 $366
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
49
適正価値
センチメント
70
強気
リスク
23
中程度のリスク
モメンタム
57
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
日中レンジ
現在 $366
52週レンジ
現在 $366
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 30.74億 USD | 28.93億 USD | 29.51億 USD | 28.86億 USD | 28.31億 USD |
| 売上原価 | 19.7億 USD | 18.91億 USD | 18.18億 USD | 17.47億 USD | 16.57億 USD |
| 粗利益 | 11.03億 USD | 10.02億 USD | 11.33億 USD | 11.39億 USD | 11.73億 USD |
| 研究開発 | 7430万 USD | 6910万 USD | 6840万 USD | 5850万 USD | 5280万 USD |
| 販売・一般管理 | 3.93億 USD | 3.39億 USD | 3.53億 USD | 3.17億 USD | 3.62億 USD |
| 営業費用 | 4.86億 USD | 4.08億 USD | 4.22億 USD | 3.75億 USD | 4.15億 USD |
| 受取利息 | 1770万 USD | 1960万 USD | 2800万 USD | 510万 USD | 100万 USD |
| 支払利息 | 60万 USD | 290万 USD | 880万 USD | 760万 USD | 850万 USD |
| 減価償却費と償却費 | 1.71億 USD | 1.55億 USD | 1.37億 USD | 1.21億 USD | 1.22億 USD |
| 営業利益 | 6.17億 USD | 5.95億 USD | 7.11億 USD | 7.64億 USD | 7.59億 USD |
| 純利益 | 4.94億 USD | 4.93億 USD | 5.93億 USD | 5.86億 USD | 6.62億 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$419.5
上昇余地(14.62%)| 種別 | 発効日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
株式分割 | 2013年9月27日 | 2:1 | — | — |
株式分割 | 2004年9月30日 | 2:1 | — | — |
株式分割 | 1987年6月2日 | 2:1 | — | — |
株式分割 | 1982年5月6日 | 2:1 | — | — |
発効済み 2013年9月27日
2:1
発効済み 2004年9月30日
2:1
発効済み 1987年6月2日
2:1
発効済み 1982年5月6日
2:1
この株式へのエクスポージャーを報告している上場投資信託です。
State Street SPDR S&P 500 ETF1557.T497.3億0.04%129.35兆 JPY0.09%¥122,850+0.12%
Vanguard Morningstar Total Stock Market ETFVTI7.66億0.03%2.3兆 USD0.03%$381.94+0.63%
Vanguard S&P 500 ETFVOO6.4億0.04%1.8兆 USD0.03%$715.59+0.61%
Vanguard Morningstar Mid-Cap ETFVO5.21億0.23%2264億 USD0.03%$81.14+0.92%
iShares Core S&P 500 ETFIVV3.4億0.04%8964.4億 USD0.03%$781.97+0.60%
Vanguard Morningstar Growth ETFVUG3.18億0.08%3846億 USD0.03%$91.97+0.72%
State Street SPDR S&P 500 ETFSPY3.14億0.04%8172億 USD0.09%$778.57+0.60%
Invesco S&P 500 Equal Weight ETFRSP2.13億0.22%977.83億 USD0.20%$213.04+0.55%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Mid-Cap ETFVO
iShares Core S&P 500 ETFIVV
Vanguard Morningstar Growth ETFVUG
State Street SPDR S&P 500 ETFSPY
Invesco S&P 500 Equal Weight ETFRSPAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。